Methodological concerns regarding "Use of high-dose steroid therapy: addition of anakinra in the treatment of severe COVID-19". [PDF]
Yıldırım F.
europepmc +1 more source
Prophylactic Anakinra to Prevent Neurotoxicity After CAR T-Cell Therapy in Aggressive B-Cell Lymphomas: A Single-Center Real-World Experience. [PDF]
Schmid T +5 more
europepmc +1 more source
Idiopathic recurrent pericarditis in children: a tertiary care cohort highlighting the emergence and effectiveness of interleukin-1 blockade. [PDF]
Gunalp A +14 more
europepmc +1 more source
Dynamic hyperinflammatory response assessment using HIC scores in COVID-19: application to a large series of patients receiving anakinra. [PDF]
Amikishiyev S +16 more
europepmc +1 more source
Respiratory effects of off label anakinra in critically ill neonates: a 15-patient observational cohort study. [PDF]
De Rose DU +7 more
europepmc +1 more source
Single Intra-Articular Anakinra (IL-1Ra) Versus Betamethasone in Rabbit Post-Traumatic Knee Osteoarthritis: IL-8 Suppression and Chondrocyte Viability. [PDF]
Tepedelenlioğlu HE +6 more
europepmc +1 more source
Long-term echocardiographic findings in patients with idiopathic recurrent pericarditis treated with anakinra. [PDF]
Toker Dincer Z +5 more
europepmc +1 more source
Anakinra use in pediatric kawasaki disease: inflammation control, coronary artery outcomes, and safety. [PDF]
Kolahdoozan M +3 more
europepmc +1 more source
Real-world clinical outcomes of macrophage activation-like syndrome and hyperferritinemia in sepsis: a retrospective database analysis. [PDF]
Ouranos K +7 more
europepmc +1 more source
Long-term anakinra therapy in Schnitzler syndrome: real-world evidence on remission of neutrophilic dermatitis and systemic inflammation, safety, biomarker insights and dose optimization. [PDF]
Sikora M +3 more
europepmc +1 more source

